| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Indazoles | 3 | 2018 | 77 | 1.43 | Why? |
| Mast Cells | 2 | 2018 | 370 | 1.09 | Why? |
| Membrane Proteins | 4 | 2018 | 1733 | 1.06 | Why? |
| Receptors, IgE | 2 | 2017 | 26 | 0.89 | Why? |
| Spectrometry, Fluorescence | 2 | 2018 | 177 | 0.88 | Why? |
| Radius | 1 | 2019 | 13 | 0.83 | Why? |
| Bone Morphogenetic Protein 2 | 1 | 2019 | 24 | 0.83 | Why? |
| Gelatin | 1 | 2019 | 39 | 0.82 | Why? |
| Histidine | 2 | 2018 | 72 | 0.79 | Why? |
| Benzene Derivatives | 1 | 2018 | 6 | 0.78 | Why? |
| Electromyography | 2 | 2018 | 278 | 0.77 | Why? |
| S100 Calcium Binding Protein A6 | 1 | 2018 | 2 | 0.77 | Why? |
| Antineoplastic Agents | 7 | 2018 | 3550 | 0.76 | Why? |
| Magnetics | 1 | 2019 | 66 | 0.76 | Why? |
| Microspheres | 2 | 2019 | 261 | 0.75 | Why? |
| Ecology | 2 | 2018 | 140 | 0.73 | Why? |
| Encephalomyelitis, Autoimmune, Experimental | 1 | 2018 | 39 | 0.73 | Why? |
| Macrocyclic Compounds | 1 | 2018 | 78 | 0.72 | Why? |
| Ultrasonic Waves | 1 | 2017 | 32 | 0.72 | Why? |
| Integrin beta1 | 1 | 2017 | 20 | 0.72 | Why? |
| Chondrocytes | 1 | 2017 | 35 | 0.72 | Why? |
| Coloring Agents | 1 | 2019 | 116 | 0.71 | Why? |
| Low Density Lipoprotein Receptor-Related Protein-5 | 1 | 2017 | 2 | 0.71 | Why? |
| Copper | 2 | 2018 | 288 | 0.71 | Why? |
| Histamine | 1 | 2018 | 61 | 0.71 | Why? |
| Tissue Scaffolds | 1 | 2019 | 174 | 0.71 | Why? |
| Protein Kinase Inhibitors | 4 | 2018 | 1585 | 0.70 | Why? |
| Urbanization | 1 | 2018 | 133 | 0.70 | Why? |
| Fracture Healing | 1 | 2017 | 37 | 0.68 | Why? |
| Arthritis, Experimental | 1 | 2017 | 44 | 0.68 | Why? |
| Pyridines | 4 | 2018 | 680 | 0.67 | Why? |
| Receptor for Advanced Glycation End Products | 1 | 2018 | 100 | 0.66 | Why? |
| Interleukin-13 | 1 | 2018 | 204 | 0.65 | Why? |
| Immunoglobulin E | 3 | 2018 | 557 | 0.64 | Why? |
| Spectrum Analysis, Raman | 1 | 2019 | 311 | 0.64 | Why? |
| Human Activities | 1 | 2018 | 293 | 0.63 | Why? |
| Transforming Growth Factor beta1 | 1 | 2017 | 204 | 0.62 | Why? |
| Cell Proliferation | 11 | 2019 | 1973 | 0.60 | Why? |
| Movement | 1 | 2017 | 232 | 0.59 | Why? |
| Receptor, Fibroblast Growth Factor, Type 1 | 3 | 2018 | 29 | 0.59 | Why? |
| Industry | 1 | 2018 | 347 | 0.59 | Why? |
| Toll-Like Receptor 3 | 1 | 2018 | 391 | 0.59 | Why? |
| TOR Serine-Threonine Kinases | 1 | 2017 | 385 | 0.57 | Why? |
| Exosomes | 2 | 2020 | 567 | 0.57 | Why? |
| Receptors, Fibroblast Growth Factor | 2 | 2018 | 14 | 0.55 | Why? |
| Fluorescent Dyes | 1 | 2018 | 536 | 0.55 | Why? |
| Spinal Cord Injuries | 1 | 2018 | 270 | 0.53 | Why? |
| Up-Regulation | 3 | 2018 | 2249 | 0.53 | Why? |
| Drug Carriers | 1 | 2019 | 590 | 0.52 | Why? |
| Hand | 1 | 2017 | 449 | 0.50 | Why? |
| Apoptosis | 5 | 2018 | 2335 | 0.50 | Why? |
| Biomarkers, Tumor | 6 | 2019 | 1314 | 0.49 | Why? |
| Environmental Monitoring | 3 | 2019 | 3143 | 0.47 | Why? |
| Osteoporosis | 1 | 2017 | 410 | 0.45 | Why? |
| Fractures, Bone | 1 | 2017 | 487 | 0.43 | Why? |
| Hypersensitivity | 3 | 2018 | 1137 | 0.43 | Why? |
| Rats, Sprague-Dawley | 5 | 2018 | 987 | 0.43 | Why? |
| Liver Cirrhosis | 2 | 2018 | 1810 | 0.41 | Why? |
| Mice | 16 | 2018 | 21357 | 0.40 | Why? |
| Gene Expression | 2 | 2018 | 3332 | 0.40 | Why? |
| Carcinoma, Squamous Cell | 1 | 2018 | 902 | 0.40 | Why? |
| Refractive Errors | 1 | 2019 | 19 | 0.39 | Why? |
| Pyriform Sinus | 1 | 2018 | 16 | 0.39 | Why? |
| MicroRNAs | 3 | 2019 | 1787 | 0.38 | Why? |
| Hypopharyngeal Neoplasms | 1 | 2018 | 47 | 0.38 | Why? |
| Trametes | 1 | 2018 | 9 | 0.38 | Why? |
| Receptor, Fibroblast Growth Factor, Type 2 | 1 | 2017 | 10 | 0.36 | Why? |
| Cell Differentiation | 3 | 2019 | 1338 | 0.36 | Why? |
| Pyridazines | 1 | 2018 | 86 | 0.35 | Why? |
| Complex Mixtures | 1 | 2018 | 51 | 0.35 | Why? |
| Animals | 29 | 2020 | 78931 | 0.35 | Why? |
| Collagen Type I | 2 | 2017 | 56 | 0.35 | Why? |
| Silicon Dioxide | 1 | 2018 | 131 | 0.35 | Why? |
| Naphthalenes | 1 | 2017 | 94 | 0.34 | Why? |
| Lung Neoplasms | 3 | 2018 | 3228 | 0.34 | Why? |
| Rats | 7 | 2018 | 2764 | 0.34 | Why? |
| Pyrazoles | 3 | 2018 | 1791 | 0.33 | Why? |
| Mice, Nude | 5 | 2018 | 340 | 0.33 | Why? |
| Cell Line, Tumor | 10 | 2020 | 3608 | 0.32 | Why? |
| Theranostic Nanomedicine | 1 | 2017 | 143 | 0.32 | Why? |
| Kidney | 2 | 2020 | 3648 | 0.32 | Why? |
| Aminopyridines | 1 | 2017 | 121 | 0.32 | Why? |
| Magnetite Nanoparticles | 1 | 2017 | 109 | 0.32 | Why? |
| Protein-Tyrosine Kinases | 1 | 2017 | 158 | 0.31 | Why? |
| Heterografts | 3 | 2018 | 203 | 0.31 | Why? |
| Cholangitis, Sclerosing | 1 | 2017 | 106 | 0.30 | Why? |
| Antibodies, Antiphospholipid | 2 | 2020 | 519 | 0.30 | Why? |
| Proto-Oncogene Proteins c-met | 2 | 2018 | 40 | 0.27 | Why? |
| Structure-Activity Relationship | 5 | 2018 | 2219 | 0.27 | Why? |
| Drug Discovery | 1 | 2018 | 3092 | 0.27 | Why? |
| Piperazines | 1 | 2017 | 445 | 0.27 | Why? |
| Stereoisomerism | 2 | 2018 | 121 | 0.27 | Why? |
| Carcinoma, Non-Small-Cell Lung | 2 | 2017 | 896 | 0.27 | Why? |
| Mice, Knockout | 3 | 2018 | 1815 | 0.26 | Why? |
| Laryngoscopy | 1 | 2018 | 413 | 0.26 | Why? |
| Cell Movement | 4 | 2020 | 695 | 0.26 | Why? |
| B7-H1 Antigen | 1 | 2017 | 541 | 0.26 | Why? |
| Gastrointestinal Neoplasms | 1 | 2018 | 392 | 0.25 | Why? |
| Mice, Inbred C57BL | 3 | 2018 | 5542 | 0.24 | Why? |
| RNA, Small Interfering | 1 | 2017 | 817 | 0.24 | Why? |
| In Situ Nick-End Labeling | 2 | 2018 | 39 | 0.24 | Why? |
| Inflammation | 3 | 2020 | 13255 | 0.23 | Why? |
| Creatine | 1 | 2021 | 66 | 0.23 | Why? |
| Hypotrichosis | 1 | 2020 | 40 | 0.22 | Why? |
| Spectrometry, Mass, Electrospray Ionization | 2 | 2018 | 159 | 0.22 | Why? |
| Liver | 5 | 2018 | 4007 | 0.22 | Why? |
| Machine Learning | 1 | 2017 | 4395 | 0.22 | Why? |
| Drug Screening Assays, Antitumor | 3 | 2018 | 138 | 0.22 | Why? |
| G(M3) Ganglioside | 1 | 2020 | 25 | 0.22 | Why? |
| Cystatin C | 1 | 2021 | 125 | 0.21 | Why? |
| Gene Expression Regulation | 3 | 2018 | 4020 | 0.21 | Why? |
| Chemokines, CC | 1 | 2020 | 79 | 0.21 | Why? |
| Cytoskeletal Proteins | 1 | 2020 | 63 | 0.21 | Why? |
| Skin Diseases, Genetic | 1 | 2020 | 65 | 0.21 | Why? |
| Cytoskeleton | 1 | 2020 | 99 | 0.21 | Why? |
| Gangliosides | 1 | 2020 | 86 | 0.21 | Why? |
| Polysaccharides | 1 | 2018 | 854 | 0.21 | Why? |
| RNA | 2 | 2019 | 1278 | 0.20 | Why? |
| Cell Cycle | 2 | 2018 | 329 | 0.20 | Why? |
| Acute Kidney Injury | 1 | 2020 | 5762 | 0.20 | Why? |
| Antigens, Differentiation, T-Lymphocyte | 1 | 2020 | 146 | 0.20 | Why? |
| Diatomaceous Earth | 1 | 2018 | 1 | 0.20 | Why? |
| Struvite | 1 | 2018 | 4 | 0.20 | Why? |
| Discoidin Domain Receptor 2 | 1 | 2018 | 1 | 0.20 | Why? |
| Signal Transduction | 7 | 2018 | 7207 | 0.20 | Why? |
| Water Pollution, Chemical | 1 | 2018 | 11 | 0.19 | Why? |
| Androgen-Insensitivity Syndrome | 1 | 2018 | 1 | 0.19 | Why? |
| Environmental Restoration and Remediation | 1 | 2018 | 22 | 0.19 | Why? |
| Inhibitor of Apoptosis Proteins | 1 | 2018 | 21 | 0.19 | Why? |
| Noncommunicable Diseases | 1 | 2018 | 934 | 0.19 | Why? |
| Carbon Tetrachloride | 1 | 2018 | 27 | 0.19 | Why? |
| RNA Splice Sites | 1 | 2018 | 40 | 0.19 | Why? |
| Geologic Sediments | 1 | 2018 | 43 | 0.19 | Why? |
| Hepatic Stellate Cells | 1 | 2018 | 35 | 0.19 | Why? |
| Anoikis | 1 | 2018 | 5 | 0.19 | Why? |
| Integrin alpha5beta1 | 1 | 2018 | 8 | 0.19 | Why? |
| Collagen Type II | 1 | 2017 | 12 | 0.18 | Why? |
| Bone Regeneration | 1 | 2018 | 35 | 0.18 | Why? |
| Ajuga | 1 | 2017 | 1 | 0.18 | Why? |
| Ecdysteroids | 1 | 2017 | 2 | 0.18 | Why? |
| Soil Pollutants | 1 | 2018 | 57 | 0.18 | Why? |
| SOX9 Transcription Factor | 1 | 2017 | 43 | 0.18 | Why? |
| Chondrogenesis | 1 | 2017 | 19 | 0.18 | Why? |
| Hemofiltration | 1 | 2020 | 155 | 0.18 | Why? |
| Membrane Transport Modulators | 1 | 2017 | 11 | 0.18 | Why? |
| Heterocyclic Compounds | 1 | 2018 | 64 | 0.18 | Why? |
| Esophagogastric Junction | 1 | 2018 | 30 | 0.18 | Why? |
| Lead | 1 | 2018 | 94 | 0.18 | Why? |
| Soil | 1 | 2018 | 137 | 0.18 | Why? |
| Hyperplasia | 1 | 2018 | 204 | 0.18 | Why? |
| Proto-Oncogene Proteins c-ret | 1 | 2017 | 15 | 0.18 | Why? |
| Embryonic Development | 1 | 2017 | 55 | 0.18 | Why? |
| Ureteral Obstruction | 1 | 2018 | 61 | 0.18 | Why? |
| Osteoblasts | 1 | 2018 | 87 | 0.17 | Why? |
| Sirolimus | 2 | 2018 | 240 | 0.17 | Why? |
| Heme Oxygenase-1 | 1 | 2018 | 90 | 0.17 | Why? |
| Sulfides | 1 | 2018 | 113 | 0.17 | Why? |
| Calcinosis | 1 | 2020 | 240 | 0.17 | Why? |
| Receptors, Polymeric Immunoglobulin | 1 | 2017 | 19 | 0.17 | Why? |
| HeLa Cells | 2 | 2018 | 1303 | 0.17 | Why? |
| Osteogenesis | 1 | 2018 | 95 | 0.17 | Why? |
| Reishi | 1 | 2017 | 18 | 0.17 | Why? |
| Gene Knockdown Techniques | 1 | 2018 | 347 | 0.17 | Why? |
| Insulin-Like Growth Factor I | 1 | 2018 | 119 | 0.17 | Why? |
| Fungal Polysaccharides | 1 | 2017 | 19 | 0.17 | Why? |
| X-Rays | 1 | 2019 | 492 | 0.17 | Why? |
| Health Surveys | 1 | 2018 | 2841 | 0.17 | Why? |
| Carcinoma, Hepatocellular | 2 | 2017 | 1222 | 0.17 | Why? |
| Stomach Neoplasms | 2 | 2017 | 477 | 0.17 | Why? |
| Carcinoma, Ductal, Breast | 1 | 2018 | 149 | 0.16 | Why? |
| Metals, Heavy | 1 | 2018 | 147 | 0.16 | Why? |
| Basophils | 1 | 2017 | 179 | 0.16 | Why? |
| Biomechanical Phenomena | 1 | 2017 | 291 | 0.16 | Why? |
| Bone Marrow Cells | 1 | 2017 | 186 | 0.16 | Why? |
| Osteosarcoma | 1 | 2017 | 83 | 0.16 | Why? |
| Oculomotor Nerve Diseases | 1 | 2016 | 44 | 0.16 | Why? |
| Light | 1 | 2019 | 306 | 0.16 | Why? |
| Hyperuricemia | 1 | 2017 | 160 | 0.16 | Why? |
| Spinal Cord | 1 | 2018 | 281 | 0.16 | Why? |
| Receptors, Immunologic | 1 | 2020 | 555 | 0.16 | Why? |
| Heart Valve Diseases | 1 | 2020 | 355 | 0.16 | Why? |
| Cytokines | 5 | 2020 | 15010 | 0.15 | Why? |
| Magnetic Resonance Spectroscopy | 2 | 2018 | 881 | 0.15 | Why? |
| Primary Cell Culture | 1 | 2017 | 501 | 0.15 | Why? |
| Nanoparticles | 1 | 2018 | 2040 | 0.15 | Why? |
| Breast Neoplasms | 3 | 2019 | 3633 | 0.15 | Why? |
| Electric Stimulation Therapy | 1 | 2018 | 151 | 0.15 | Why? |
| Astrocytes | 1 | 2018 | 298 | 0.15 | Why? |
| Quantum Dots | 1 | 2017 | 129 | 0.15 | Why? |
| Receptors, Androgen | 1 | 2018 | 212 | 0.15 | Why? |
| Rabbits | 1 | 2019 | 1171 | 0.15 | Why? |
| Cell Transformation, Neoplastic | 1 | 2017 | 191 | 0.15 | Why? |
| Neural Stem Cells | 1 | 2017 | 135 | 0.15 | Why? |
| Cell-Free Nucleic Acids | 1 | 2019 | 271 | 0.15 | Why? |
| Mice, Transgenic | 3 | 2017 | 2739 | 0.15 | Why? |
| Aneurysm, Ruptured | 1 | 2016 | 109 | 0.15 | Why? |
| Diabetes Mellitus, Experimental | 1 | 2017 | 192 | 0.15 | Why? |
| Gene Ontology | 1 | 2017 | 391 | 0.15 | Why? |
| Glomerular Filtration Rate | 1 | 2021 | 1262 | 0.15 | Why? |
| Benzamides | 1 | 2018 | 421 | 0.15 | Why? |
| Gene Regulatory Networks | 2 | 2019 | 820 | 0.14 | Why? |
| Cell Membrane | 1 | 2020 | 743 | 0.14 | Why? |
| Antigens, CD | 1 | 2020 | 984 | 0.14 | Why? |
| Gene Expression Regulation, Neoplastic | 2 | 2018 | 1014 | 0.14 | Why? |
| Protein Interaction Mapping | 1 | 2017 | 487 | 0.14 | Why? |
| NF-E2-Related Factor 2 | 1 | 2018 | 373 | 0.14 | Why? |
| Hypoglycemic Agents | 2 | 2017 | 2165 | 0.14 | Why? |
| Disease Models, Animal | 5 | 2018 | 10998 | 0.14 | Why? |
| Phosphorylation | 3 | 2020 | 1060 | 0.14 | Why? |
| Databases, Nucleic Acid | 1 | 2017 | 272 | 0.14 | Why? |
| Neovascularization, Pathologic | 1 | 2017 | 305 | 0.13 | Why? |
| Creatinine | 1 | 2020 | 1443 | 0.13 | Why? |
| Mice, Inbred BALB C | 3 | 2018 | 5814 | 0.13 | Why? |
| Angiogenesis Inhibitors | 1 | 2017 | 395 | 0.13 | Why? |
| Bone Neoplasms | 1 | 2017 | 287 | 0.13 | Why? |
| Male | 27 | 2021 | 367725 | 0.13 | Why? |
| NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2018 | 581 | 0.13 | Why? |
| RNA, Long Noncoding | 1 | 2018 | 408 | 0.13 | Why? |
| Plasma Exchange | 1 | 2020 | 763 | 0.12 | Why? |
| Water Pollutants, Chemical | 1 | 2018 | 410 | 0.12 | Why? |
| Th17 Cells | 1 | 2018 | 657 | 0.12 | Why? |
| Computational Biology | 2 | 2019 | 4514 | 0.12 | Why? |
| Molecular Structure | 3 | 2018 | 1539 | 0.12 | Why? |
| Receptors, KIR | 1 | 2013 | 167 | 0.12 | Why? |
| Female | 27 | 2021 | 380317 | 0.12 | Why? |
| Inflammasomes | 1 | 2018 | 710 | 0.11 | Why? |
| Gene Expression Profiling | 3 | 2019 | 3788 | 0.11 | Why? |
| Humans | 43 | 2021 | 930598 | 0.11 | Why? |
| Th1 Cells | 1 | 2018 | 1228 | 0.11 | Why? |
| Cell Survival | 3 | 2018 | 1581 | 0.11 | Why? |
| Renal Replacement Therapy | 1 | 2020 | 1530 | 0.11 | Why? |
| Drug Design | 2 | 2018 | 2627 | 0.11 | Why? |
| Muscle, Skeletal | 1 | 2018 | 915 | 0.11 | Why? |
| Intracranial Aneurysm | 1 | 2016 | 504 | 0.11 | Why? |
| Kinetics | 1 | 2019 | 3238 | 0.11 | Why? |
| Neoplasm Recurrence, Local | 1 | 2018 | 1063 | 0.11 | Why? |
| Lymph Nodes | 1 | 2018 | 1060 | 0.11 | Why? |
| Adenocarcinoma | 1 | 2018 | 651 | 0.11 | Why? |
| Nitric Oxide | 1 | 2018 | 769 | 0.11 | Why? |
| Recombination, Genetic | 1 | 2017 | 1265 | 0.11 | Why? |
| Magnetic Resonance Imaging | 1 | 2017 | 6551 | 0.10 | Why? |
| Pancreatitis | 1 | 2018 | 688 | 0.10 | Why? |
| Proteome | 1 | 2010 | 1812 | 0.10 | Why? |
| Acute Lung Injury | 1 | 2018 | 904 | 0.10 | Why? |
| Critical Illness | 4 | 2021 | 17281 | 0.10 | Why? |
| Astigmatism | 1 | 2019 | 6 | 0.10 | Why? |
| China | 9 | 2021 | 50654 | 0.10 | Why? |
| Aldehyde Oxidase | 1 | 2018 | 10 | 0.10 | Why? |
| Deuterium | 1 | 2018 | 21 | 0.10 | Why? |
| Protein Interaction Maps | 1 | 2017 | 1333 | 0.10 | Why? |
| Vaccines | 1 | 2018 | 3692 | 0.09 | Why? |
| Pyrimidines | 1 | 2017 | 1557 | 0.09 | Why? |
| Intracranial Hemorrhages | 1 | 2017 | 1170 | 0.09 | Why? |
| Pyroglyphidae | 1 | 2018 | 52 | 0.09 | Why? |
| Receptors, Platelet-Derived Growth Factor | 1 | 2017 | 8 | 0.09 | Why? |
| Transplantation, Heterologous | 1 | 2018 | 77 | 0.09 | Why? |
| Immunosuppressive Agents | 1 | 2017 | 6331 | 0.09 | Why? |
| Succinimides | 1 | 2017 | 3 | 0.09 | Why? |
| G1 Phase Cell Cycle Checkpoints | 1 | 2017 | 26 | 0.09 | Why? |
| Liver Neoplasms | 2 | 2017 | 1666 | 0.09 | Why? |
| Porosity | 1 | 2018 | 185 | 0.09 | Why? |
| Controlled Clinical Trials as Topic | 1 | 2018 | 53 | 0.09 | Why? |
| Tumor Cells, Cultured | 2 | 2018 | 254 | 0.09 | Why? |
| Neoplasm Transplantation | 1 | 2017 | 55 | 0.09 | Why? |
| Polyethyleneimine | 1 | 2017 | 37 | 0.09 | Why? |
| Recovery of Function | 1 | 2018 | 2461 | 0.09 | Why? |
| Half-Life | 1 | 2018 | 298 | 0.09 | Why? |
| Neoplasms, Experimental | 2 | 2018 | 67 | 0.09 | Why? |
| Receptors, Vascular Endothelial Growth Factor | 1 | 2017 | 61 | 0.09 | Why? |
| Protein Transport | 2 | 2020 | 487 | 0.09 | Why? |
| Recombinant Proteins | 1 | 2018 | 3786 | 0.09 | Why? |
| Cognition | 1 | 2017 | 1394 | 0.08 | Why? |
| Proto-Oncogene Proteins c-bcl-2 | 2 | 2018 | 127 | 0.08 | Why? |
| Oxidative Stress | 1 | 2018 | 2050 | 0.08 | Why? |
| Renal Insufficiency, Chronic | 1 | 2021 | 2654 | 0.08 | Why? |
| RNA, Messenger | 2 | 2019 | 5131 | 0.08 | Why? |
| Interferon Type I | 1 | 2020 | 2789 | 0.08 | Why? |
| Coculture Techniques | 1 | 2017 | 258 | 0.08 | Why? |
| Endovascular Procedures | 1 | 2016 | 1302 | 0.08 | Why? |
| Gene Transfer Techniques | 1 | 2017 | 134 | 0.08 | Why? |
| Alzheimer Disease | 1 | 2017 | 1020 | 0.08 | Why? |
| Databases, Chemical | 1 | 2017 | 196 | 0.08 | Why? |
| Cities | 1 | 2018 | 4937 | 0.08 | Why? |
| Delayed-Action Preparations | 1 | 2018 | 291 | 0.08 | Why? |
| Ferric Compounds | 1 | 2017 | 136 | 0.08 | Why? |
| Blood Coagulation Disorders | 1 | 2020 | 2040 | 0.08 | Why? |
| Plant Extracts | 1 | 2017 | 1514 | 0.08 | Why? |
| CD40 Ligand | 1 | 2006 | 121 | 0.08 | Why? |
| Folic Acid | 1 | 2017 | 172 | 0.08 | Why? |
| Publication Bias | 1 | 2017 | 241 | 0.08 | Why? |
| Coronavirus Infections | 8 | 2020 | 253789 | 0.08 | Why? |
| CD40 Antigens | 1 | 2006 | 118 | 0.08 | Why? |
| Network Meta-Analysis | 1 | 2018 | 426 | 0.08 | Why? |
| Aged | 14 | 2021 | 215776 | 0.07 | Why? |
| Cell Line | 2 | 2018 | 12040 | 0.07 | Why? |
| Betacoronavirus | 6 | 2020 | 204454 | 0.07 | Why? |
| Chemotherapy, Adjuvant | 1 | 2018 | 606 | 0.07 | Why? |
| Pneumonia, Viral | 7 | 2020 | 243684 | 0.07 | Why? |
| Neurosurgical Procedures | 1 | 2016 | 1738 | 0.07 | Why? |
| Middle Aged | 15 | 2021 | 270681 | 0.07 | Why? |
| Transfection | 1 | 2017 | 864 | 0.07 | Why? |
| Forecasting | 1 | 2018 | 4492 | 0.07 | Why? |
| Macaca fascicularis | 1 | 2018 | 1009 | 0.07 | Why? |
| Dose-Response Relationship, Drug | 2 | 2018 | 3776 | 0.07 | Why? |
| Evolution, Molecular | 1 | 2017 | 3691 | 0.07 | Why? |
| Aged, 80 and over | 6 | 2020 | 88759 | 0.07 | Why? |
| Adult | 14 | 2020 | 244371 | 0.06 | Why? |
| Young Adult | 7 | 2020 | 93724 | 0.06 | Why? |
| Polyethylene Glycols | 1 | 2017 | 574 | 0.06 | Why? |
| Chiroptera | 1 | 2017 | 3530 | 0.06 | Why? |
| Computer Simulation | 1 | 2017 | 4982 | 0.06 | Why? |
| Educational Status | 1 | 2019 | 1451 | 0.06 | Why? |
| Interleukin-6 | 1 | 2020 | 7522 | 0.06 | Why? |
| Allergens | 1 | 2018 | 728 | 0.06 | Why? |
| Population Health | 1 | 2018 | 504 | 0.06 | Why? |
| Multiple Sclerosis | 1 | 2018 | 2600 | 0.06 | Why? |
| Keratin-8 | 1 | 2010 | 2 | 0.06 | Why? |
| Demography | 1 | 2018 | 1660 | 0.06 | Why? |
| Sex Distribution | 1 | 2019 | 2083 | 0.06 | Why? |
| Phosphatidylinositol 4,5-Diphosphate | 1 | 2020 | 10 | 0.06 | Why? |
| LLC-PK1 Cells | 1 | 2020 | 27 | 0.05 | Why? |
| Diglycerides | 1 | 2020 | 32 | 0.05 | Why? |
| Administration, Oral | 1 | 2018 | 2340 | 0.05 | Why? |
| p300-CBP Transcription Factors | 1 | 2020 | 13 | 0.05 | Why? |
| CD4-Positive T-Lymphocytes | 3 | 2020 | 4545 | 0.05 | Why? |
| Contrast Media | 1 | 2017 | 1011 | 0.05 | Why? |
| Chemotaxis, Leukocyte | 1 | 2020 | 82 | 0.05 | Why? |
| Sphingomyelins | 1 | 2020 | 54 | 0.05 | Why? |
| Acetylation | 1 | 2020 | 124 | 0.05 | Why? |
| Keratin-18 | 1 | 2010 | 114 | 0.05 | Why? |
| Down-Regulation | 2 | 2017 | 1416 | 0.05 | Why? |
| Actins | 1 | 2020 | 108 | 0.05 | Why? |
| Antibodies, Anti-Idiotypic | 1 | 2020 | 93 | 0.05 | Why? |
| Models, Biological | 1 | 2017 | 4907 | 0.05 | Why? |
| Risk Factors | 3 | 2020 | 71621 | 0.05 | Why? |
| Killer Cells, Natural | 2 | 2020 | 2093 | 0.05 | Why? |
| Alcohols | 1 | 2010 | 86 | 0.05 | Why? |
| Bays | 1 | 2018 | 24 | 0.05 | Why? |
| T-Lymphocytes, Regulatory | 1 | 2006 | 698 | 0.05 | Why? |
| Estuaries | 1 | 2018 | 25 | 0.05 | Why? |
| Kidney Function Tests | 1 | 2021 | 520 | 0.05 | Why? |
| Proliferating Cell Nuclear Antigen | 1 | 2018 | 18 | 0.05 | Why? |
| Caspase 9 | 1 | 2018 | 38 | 0.05 | Why? |
| GPI-Linked Proteins | 1 | 2020 | 317 | 0.05 | Why? |
| Age Distribution | 1 | 2019 | 3567 | 0.05 | Why? |
| Phosphatidylcholines | 1 | 2018 | 68 | 0.05 | Why? |
| Interleukin-10 | 1 | 2006 | 1409 | 0.05 | Why? |
| Recycling | 1 | 2018 | 71 | 0.05 | Why? |
| Phylogeny | 1 | 2017 | 13341 | 0.05 | Why? |
| Antibodies, Anticardiolipin | 1 | 2020 | 208 | 0.05 | Why? |
| Alloxan | 1 | 2017 | 2 | 0.05 | Why? |
| COS Cells | 1 | 2018 | 157 | 0.05 | Why? |
| Solutions | 1 | 2018 | 121 | 0.05 | Why? |
| Oceans and Seas | 1 | 2018 | 73 | 0.05 | Why? |
| Flow Cytometry | 2 | 2017 | 2393 | 0.05 | Why? |
| Urban Population | 1 | 2019 | 2000 | 0.04 | Why? |
| Caspase 3 | 1 | 2018 | 218 | 0.04 | Why? |
| Substrate Specificity | 1 | 2020 | 639 | 0.04 | Why? |
| bcl-2-Associated X Protein | 1 | 2017 | 45 | 0.04 | Why? |
| Sulfhydryl Compounds | 1 | 2018 | 104 | 0.04 | Why? |
| Spectroscopy, Fourier Transform Infrared | 1 | 2018 | 207 | 0.04 | Why? |
| Mutation | 1 | 2018 | 12376 | 0.04 | Why? |
| SEER Program | 1 | 2018 | 146 | 0.04 | Why? |
| Molecular Imaging | 1 | 2018 | 110 | 0.04 | Why? |
| Sodium-Glucose Transporter 2 | 1 | 2017 | 111 | 0.04 | Why? |
| Xenograft Model Antitumor Assays | 1 | 2017 | 274 | 0.04 | Why? |
| Molecular Docking Simulation | 2 | 2017 | 6902 | 0.04 | Why? |
| Cell Adhesion | 1 | 2018 | 230 | 0.04 | Why? |
| Cell Self Renewal | 1 | 2017 | 55 | 0.04 | Why? |
| Gene Expression Regulation, Developmental | 1 | 2017 | 159 | 0.04 | Why? |
| Transduction, Genetic | 1 | 2018 | 273 | 0.04 | Why? |
| Neurogenesis | 1 | 2017 | 64 | 0.04 | Why? |
| Pedigree | 1 | 2018 | 502 | 0.04 | Why? |
| Proline | 1 | 2018 | 345 | 0.04 | Why? |
| Diabetes Mellitus, Type 2 | 1 | 2017 | 6166 | 0.04 | Why? |
| Rural Population | 1 | 2019 | 2408 | 0.04 | Why? |
| Support Vector Machine | 1 | 2018 | 330 | 0.04 | Why? |
| ROC Curve | 2 | 2018 | 6024 | 0.04 | Why? |
| Rats, Wistar | 1 | 2017 | 621 | 0.04 | Why? |
| Metabolome | 1 | 2020 | 624 | 0.04 | Why? |
| Lymphatic Metastasis | 1 | 2018 | 537 | 0.04 | Why? |
| Neoplasm Invasiveness | 1 | 2017 | 582 | 0.04 | Why? |
| Lymphocyte Activation | 2 | 2020 | 2742 | 0.04 | Why? |
| Amino Acids | 1 | 2018 | 552 | 0.04 | Why? |
| Immunotherapy | 1 | 2018 | 2421 | 0.03 | Why? |
| Benzhydryl Compounds | 1 | 2017 | 240 | 0.03 | Why? |
| Uric Acid | 1 | 2017 | 285 | 0.03 | Why? |
| Random Allocation | 1 | 2017 | 773 | 0.03 | Why? |
| Tandem Mass Spectrometry | 1 | 2020 | 1031 | 0.03 | Why? |
| Metabolomics | 1 | 2020 | 921 | 0.03 | Why? |
| Reference Values | 1 | 2017 | 795 | 0.03 | Why? |
| Lipopolysaccharides | 1 | 2018 | 848 | 0.03 | Why? |
| Randomized Controlled Trials as Topic | 2 | 2017 | 10649 | 0.03 | Why? |
| Logistic Models | 1 | 2019 | 9089 | 0.03 | Why? |
| Wound Healing | 1 | 2018 | 424 | 0.03 | Why? |
| Intensive Care Units | 1 | 2020 | 29594 | 0.03 | Why? |
| Kidney Transplantation | 1 | 2013 | 5397 | 0.03 | Why? |
| Glucosides | 1 | 2017 | 359 | 0.03 | Why? |
| Blood Glucose | 2 | 2017 | 3642 | 0.03 | Why? |
| CD8-Positive T-Lymphocytes | 2 | 2020 | 5837 | 0.03 | Why? |
| Models, Molecular | 1 | 2017 | 7616 | 0.03 | Why? |
| Hypoglycemia | 1 | 2017 | 406 | 0.03 | Why? |
| Prevalence | 2 | 2019 | 25773 | 0.03 | Why? |
| Retrospective Studies | 2 | 2021 | 105322 | 0.03 | Why? |
| Genes, Viral | 1 | 2017 | 1428 | 0.03 | Why? |
| Algorithms | 2 | 2019 | 7346 | 0.03 | Why? |
| Swine | 1 | 2020 | 3352 | 0.03 | Why? |
| Adolescent | 4 | 2020 | 86841 | 0.03 | Why? |
| Cross-Sectional Studies | 2 | 2019 | 53120 | 0.03 | Why? |
| Immunohistochemistry | 1 | 2018 | 2275 | 0.03 | Why? |
| Immunoglobulin G | 2 | 2020 | 21571 | 0.03 | Why? |
| Neoplasm Staging | 1 | 2018 | 1999 | 0.03 | Why? |
| Limit of Detection | 1 | 2018 | 2698 | 0.03 | Why? |
| Catalytic Domain | 1 | 2017 | 1757 | 0.03 | Why? |
| Prognosis | 3 | 2018 | 32490 | 0.03 | Why? |
| Leukocyte Count | 1 | 2020 | 3178 | 0.03 | Why? |
| Single-Cell Analysis | 1 | 2020 | 2450 | 0.03 | Why? |
| Case-Control Studies | 1 | 2018 | 17671 | 0.02 | Why? |
| Dogs | 1 | 2017 | 2529 | 0.02 | Why? |
| Asthma | 1 | 2018 | 4383 | 0.02 | Why? |
| Protein Conformation | 1 | 2020 | 4386 | 0.02 | Why? |
| Follow-Up Studies | 2 | 2018 | 17020 | 0.02 | Why? |
| Gene Frequency | 1 | 2013 | 1210 | 0.02 | Why? |
| Sequence Analysis, DNA | 1 | 2017 | 2830 | 0.02 | Why? |
| Coronavirus | 1 | 2017 | 18339 | 0.02 | Why? |
| Immunoglobulin A | 1 | 2020 | 3567 | 0.02 | Why? |
| Survival Analysis | 1 | 2021 | 7592 | 0.02 | Why? |
| Biomarkers | 2 | 2021 | 23361 | 0.02 | Why? |
| Protein Domains | 1 | 2020 | 6563 | 0.02 | Why? |
| Mice, Inbred C3H | 1 | 2006 | 102 | 0.02 | Why? |
| HEK293 Cells | 1 | 2020 | 8394 | 0.02 | Why? |
| Hyperglycemia | 1 | 2017 | 1363 | 0.02 | Why? |
| Cells, Cultured | 1 | 2018 | 5835 | 0.02 | Why? |
| Polymorphism, Genetic | 1 | 2013 | 1074 | 0.02 | Why? |
| Lung | 2 | 2020 | 31049 | 0.02 | Why? |
| Acute Disease | 1 | 2018 | 6029 | 0.02 | Why? |
| Pandemics | 7 | 2020 | 389249 | 0.02 | Why? |
| Cohort Studies | 2 | 2020 | 36005 | 0.02 | Why? |
| Adoptive Transfer | 1 | 2006 | 250 | 0.02 | Why? |
| Risk Assessment | 2 | 2018 | 25439 | 0.02 | Why? |
| Binding Sites | 1 | 2017 | 6201 | 0.02 | Why? |
| Survival Rate | 1 | 2018 | 9206 | 0.02 | Why? |
| Graft Survival | 1 | 2006 | 587 | 0.02 | Why? |
| Genotype | 1 | 2013 | 4697 | 0.01 | Why? |
| Immune Tolerance | 1 | 2006 | 608 | 0.01 | Why? |
| Treatment Outcome | 1 | 2017 | 51732 | 0.01 | Why? |
| Neoplasms | 1 | 2018 | 17251 | 0.01 | Why? |
| Child | 1 | 2018 | 70012 | 0.01 | Why? |
| Hypertension | 1 | 2020 | 8895 | 0.01 | Why? |
| Disease Progression | 1 | 2017 | 13580 | 0.01 | Why? |
| Hospitals | 1 | 2018 | 11793 | 0.01 | Why? |
| Hospital Mortality | 1 | 2021 | 22087 | 0.01 | Why? |
| Genome, Viral | 1 | 2017 | 13157 | 0.01 | Why? |
| Pregnancy | 1 | 2017 | 23879 | 0.01 | Why? |
| Severity of Illness Index | 1 | 2020 | 48226 | 0.01 | Why? |
| RNA, Viral | 1 | 2017 | 32276 | 0.01 | Why? |